Provider Profile Name: TRAVA (Trava Health)
Website: taketrava.com
Founded: 2023
Headquarters: Houston, TX
Provider Type: Telehealth — Virtual Only, Direct-to-Consumer
Operating Details
- Fully virtual — online health assessment, licensed provider review (often via patient portal messaging), home delivery
- Founded 2023, based in Houston, TX; one co-founder owns a sterile compounding pharmacy, giving the platform strong pharmacy infrastructure roots
- Operates nationwide with licensed providers across dozens of states
- Batches tested with Eagle Analytical, an FDA-registered analytics laboratory
- No insurance accepted; no membership fee; all-inclusive pricing
- HSA/FSA eligible
- Free next-day air shipping once prescription is filled
- Support hours: Monday–Friday 9am–9pm CT; weekends 9am–5pm CT; available via email, phone, and patient portal messaging
- 59 Trustpilot reviews
- Also offers NAD+ and sermorelin as longevity treatments
Approach Trava markets itself as offering “the best-priced GLP-1 in the industry,” with a mission to make healthcare more accessible starting with weight loss solutions. The company explicitly uses compounded semaglutide and tirzepatide mixed with vitamin B12, and is clear that these compounded medications are not FDA-approved.
About the Company
Trava Health is a telehealth clinic founded in 2023 and based in Houston, Texas. One co-founder owns a sterile compounding pharmacy, and the company emphasizes transparency, quality care, and customer satisfaction as its founding principles.
The pharmacy ownership background of Trava’s founders is a meaningful differentiator in this review series. Most GLP-1 telehealth platforms are founded by technology or healthcare entrepreneurs who then establish pharmacy partnerships — Trava’s co-founder bringing direct sterile compounding pharmacy ownership to the platform means the clinical and pharmaceutical quality standards are informed by insider expertise rather than arm’s-length vendor relationships.
To bolster confidence in product quality, Trava highlights quality measures including testing batches with Eagle Analytical, an FDA-registered analytics laboratory — a practice that provides independent potency and sterility verification beyond what many platforms in this review series disclose.
Patients are required to complete an online assessment and evaluation with a licensed medical provider before any prescription is issued — ensuring treatments are personalized and based on a thorough understanding of individual health needs and medical history.
GLP-1 Offerings and Weight Loss Services
Compounded Semaglutide with B12:
- Weekly injectable — semaglutide combined with vitamin B12; dose-based pricing tiers
- Monthly or quarterly supply options
Compounded Tirzepatide with B12:
- Weekly injectable — tirzepatide combined with vitamin B12; dose-based pricing tiers
- Monthly or quarterly supply options; titration bundles or same-dose bundles available
Longevity Treatments (separate from GLP-1 program):
- NAD+ injections starting at $149.19/month; sermorelin starting at $149.19/month with quarterly option at $528.91
What’s included:
- Entry pricing includes initial online doctor consultation, medication vial, syringes and alcohol pads, and free overnight shipping — no membership fees or hidden charges
- Ongoing provider access through patient portal messaging
- Option to use an outside pharmacy if preferred, though the patient pays that pharmacy directly — using Trava’s partner pharmacies keeps costs within the platform price
Pricing — and What Reviewers Say
Trava uses dose-based pricing — meaning the monthly cost increases as the dose escalates through titration. This is different from the flat-dose models offered by Mochi Health, Eden, and Ivy Rx:
Compounded Semaglutide with B12:
- Starting at $119.96/month for the lowest dose; pricing increases with dose escalation
Compounded Tirzepatide with B12:
- Starting at $197.98/month; ranging up to approximately $387.98/month at higher maintenance doses
- Quarterly 3-month plans available — for example, the 15mg tirzepatide dose costs approximately $388/month on a monthly plan, or slightly less at around $360/month if prepaid quarterly
What reviewers say about pricing: Trava’s all-inclusive pricing is genuinely competitive — the $119.96/month entry point for compounded semaglutide with B12 is among the lowest in this review series for an all-inclusive telehealth program. The dose-based escalation model means patients who reach higher maintenance doses will pay significantly more than the entry price, which should be accounted for in total cost planning. The inclusion of free next-day air shipping — a meaningful logistical upgrade from the standard 5–7 business day ground shipping offered by most platforms — adds real value that partially offsets the dose-escalation cost trajectory.
Reviews from Trustpilot and Google
TRAVA has 59 Trustpilot reviews at time of writing — the smallest independent review pool among the substantive telehealth platforms in this review series.
What patients praise:
- Early experiences described as overwhelmingly positive — prices reasonable, online doctor support good, shipping fast
- Free next-day air shipping praised as a meaningful differentiator
- Strong pharmacy background of founders cited as a trust signal in independent reviews
- Weight loss results reported positively by multiple reviewers across both semaglutide and tirzepatide programs
Common complaints:
Customer service responsiveness — the dominant documented concern: In mid-2025, as demand for compounded GLP-1s continued to grow, some Trava customers experienced delays — orders taking two or more weeks, lack of timely updates, and difficulty reaching support. An independent reviewer reached out to Trava’s customer service in July 2025 and received no response after 8 days — confirming what many were reporting online at the time.
At least one long-term patient describes a positive early experience that deteriorated when a medical issue arose — finding that provider responses were inconsistent in quality, with some providers not reading questions thoroughly before responding. This suggests a provider quality variability issue in addition to the customer support volume problem.
Compounding Pharmacies Used
Trava works with multiple compounding pharmacy partners including Postmeds Inc. (Truepill), EHT Pharmacy (Curexa), Apostrophe Pharmacy, XeCare, and Optimal Balance Pharmacy. The Telehealth Consent also discloses commercial relationships with Wells American Inc. doing business as Promed Pharmacy and Optimal Balance Pharmacy doing business as OBP.
The public disclosure of multiple named pharmacy partners is a meaningful transparency positive — patients can independently verify licensure and regulatory standing for any of the listed pharmacies before their prescription is filled. Trava tests batches with Eagle Analytical, an FDA-registered analytics laboratory — providing independent potency and sterility verification that goes beyond what most platforms in this series disclose. Patients should ask which specific pharmacy will fulfill their prescription for each order, as the fulfilling partner may vary.
Note: TRAVA’s pharmacy-founder background, Eagle Analytical batch testing, named pharmacy partner disclosure, and competitive entry pricing ($119.96/month for semaglutide) are meaningful positives. The dose-based pricing escalation — where higher maintenance doses cost significantly more than the entry price — should be factored into total cost planning before enrollment. The customer service responsiveness issues documented in mid-2025 are the platform’s most significant risk flag: an independent review confirmed an 8-day non-response window at the time of testing. With only 59 Trustpilot reviews, the statistical confidence of the aggregate rating is limited. Compounded medications are not FDA-approved. Always consult a licensed medical provider before beginning any GLP-1 program.





